Regulation of nuclear factor κB transactivation -: Implication of phosphatidylinositol 3-kinase and protein kinase C ξ IN c-Rel activation by tumor necrosis factor α

被引:87
作者
Martin, AG [1 ]
San-Antonio, B [1 ]
Fresno, M [1 ]
机构
[1] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain
关键词
D O I
10.1074/jbc.M011313200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transactivation by c-Rel (nuclear factor kappaB) was dependent on phosphorylation of several serines in the transactivation domain, indicating that it is a phosphorylation-dependent Ser-rich domain. By Ser --> Ala mutational and deletion analysis, we have identified two regions in this domain: 1) a C-terminal region (amino acids 540-588), which is required for basal activity; and 2) the 422-540 region, which responds to external stimuli as tumor necrosis factor (TNF) alpha or phorbol myristate acetate plus ionomycin. Ser from 454 to 473 were shown to be required for TNF alpha -induced activation, whereas Ser between 492 and 519 were required for phorbol myristate acetate plus ionomycin activation. Phosphatidylinositol S-kinase (PI3K) and protein kinase C (PKC) zeta were identified as downstream signaling molecules of TNF alpha -activation of c-Rel transactivating activity. Interestingly, dominant negative forms of PI3K inhibited PKC zeta activation and dominant negative PKC zeta inhibited PI3K-mediated activation of c-Rel transactivating activity, indicating a cross-talk between both enzymes. We have identified the critical role of different Ser for PKC zeta- and PI3K-mediated responses. Interestingly, those c-Rel mutants not only did not respond to TNF alpha but also acted as dominant negative forms of nuclear factor kappaB activation.
引用
收藏
页码:15840 / 15849
页数:10
相关论文
共 47 条
  • [1] Regulation of NF-κB RelA phosphorylation and transcriptional activity by p21ras and protein kinase Cζ in primary endothelial cells
    Anrather, J
    Csizmadia, V
    Soares, MP
    Winkler, H
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (19) : 13594 - 13603
  • [2] The NF-kappa B and I kappa B proteins: New discoveries and insights
    Baldwin, AS
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 : 649 - 683
  • [3] THE MOUSE C-REL PROTEIN HAS AN N-TERMINAL REGULATORY DOMAIN AND A C-TERMINAL TRANSCRIPTIONAL TRANSACTIVATION DOMAIN
    BULL, P
    MORLEY, KL
    HOEKSTRA, MF
    HUNTER, T
    VERMA, IM
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (10) : 5473 - 5485
  • [4] Chen CL, 1999, MOL CELL BIOL, V19, P307
  • [5] Degradation of proto-oncoprotein c-Rel by the ubiquitin-proteasome pathway
    Chen, E
    Hrdlickova, R
    Nehyba, J
    Longo, DL
    Bose, HR
    Li, CCH
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (52) : 35201 - 35207
  • [6] Regulation of protein kinase C ζ by PI 3-kinase and PDK-1
    Chou, MM
    Hou, WM
    Johnson, J
    Graham, LK
    Lee, MH
    Chen, CS
    Newton, AC
    Schaffhausen, BS
    Toker, A
    [J]. CURRENT BIOLOGY, 1998, 8 (19) : 1069 - 1077
  • [7] INHIBITION OF PROTEIN-KINASE-C ZETA-SUBSPECIES BLOCKS THE ACTIVATION OF AN NF-KAPPA-B-LIKE ACTIVITY IN XENOPUS-LAEVIS OOCYTES
    DOMINGUEZ, I
    SANZ, L
    ARENZANASEISDEDOS, F
    DIAZMECO, MT
    VIRELIZIER, JL
    MOSCAT, J
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (02) : 1290 - 1295
  • [8] Protein kinase C-zeta mediates NF-kappa B activation in human immunodeficiency virus-infected monocytes
    Folgueira, L
    McElhinny, JA
    Bren, GD
    MacMorran, WS
    DiazMeco, MT
    Moscat, J
    Paya, CV
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (01) : 223 - 231
  • [9] Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor
    Gerondakis, S
    Strasser, A
    Metcalf, D
    Grigoriadis, G
    Scheerlinck, JPY
    Grumont, RJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (08) : 3405 - 3409
  • [10] NF-κB and rel proteins:: Evolutionarily conserved mediators of immune responses
    Ghosh, S
    May, MJ
    Kopp, EB
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 : 225 - 260